The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
Apoptotic Body Engulfment by a Human Stellate Cell Line Is Profibrogenic
Open accessAbstract
Hepatocyte apoptosis and stellate cell activation are both features of chronic liver diseases, but a relationship between these events has not been explored. In macrophages, engulfment of apoptotic bodies induces expression of transforming growth factor-beta (TGF-beta), a profibrogenic cytokine. We examined whether a similar response occurs in stellate cells. Fluorescently labeled hepatocyte apoptotic bodies were added to cultures of primary and immortalized human stellate cells. Stellate cells, but not hepatocytes, readily engulfed apoptotic bodies in a time-dependent manner as assessed by confocal microscopy. The activation of primary and immortalized human stellate cells after incubation with apoptotic bodies, as well as their fibrogenic activity, was indicated by an increase in alpha-smooth muscle actin (primary cells), TGF-beta1, and collagen alpha1(I) mRNA (primary and immortalized cells). The profibrogenic response was dependent upon apoptotic body engulfment, because nocodazole, a microtubule-inhibiting agent, blocked both the engulfment and the increase of TGF-beta1 and collagen alpha1(I) mRNA. As described in primary rodent stellate cells, up-regulation of collagen alpha1(I) mRNA was inhibited by a PI-3K inhibitor (LY294002) and a p38 mitogen-activated protein kinase inhibitor (SB203580) in LX-1 cells. In conclusion, these data support a model in which engulfment of hepatocyte apoptotic bodies by stellate cells leads to a fibrogenic response by eliciting a kinase-signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Earlier in vitro studies reported that HSC line LX-1 is able to engulf apoptotic bodies of hepatocytes, which induced pro-fibrogenic activation in vitro via a nicotinamide adenine dinucleotide phosphate oxidase20 and phosphoinositide 3-kinase/p38 mitogen-activated protein kinase-dependent manner21.”
From Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis (2020) · cites this paper as [21]
In the citing paper
“Dying or damaged hepatocytes secrete damage-associated molecular patterns including high mobility group box 1 protein (HMGB1), osteopontin (SPP1), purinoceptor 14 (P2Y14) ligands, apoptotic bodies, microRNA (miRNA), and DNA that can be packaged into microvesicles and directly taken up by HSCs, leading to their activation into collagen-producing myofibroblasts (see “Cellular plasticity”, below) (23”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 3×
“Current concepts derived from developmental biology suggest that apoptosis and clearance of apoptotic bodies are evolutionary conserved processes to limit or even prevent inflammatory responses (Fadok et al, 1998; Savill, 2000).”
BackgroundMechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,453
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Self-citationProduct Differentiation by Analysis of DNA Melting Curves during the Polymerase Chain Reaction
Ririe, K. M., Rasmussen, R. P., & Wittwer, C. T. (1997) · Analytical Biochemistry · doi:10.1006/abio.1996.9916 · Cited by 1,663
Corpse clearance defines the meaning of cell death
Savill, J., & Fadok, V. A. (2000) · Nature · doi:10.1038/35037722 · Cited by 1,572
Hepatic lipocytes: the principal collagen-producing cells of normal rat liver.
Friedman, S. L., Roll, F. J., Boyles, J., & Bissell, D. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8681 · Cited by 859
Self-citationHistory, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells
Geerts, A. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17550 · Cited by 740
Fadok, V., de Cathelineau, A., Daleke, D. L., Henson, P., & Bratton, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003649200 · Cited by 689
Transport and Storage of Vitamin A
Blomhoff, R., Green, M. H., Berg, T., & Norum, K. R. (1990) · Science · doi:10.1126/science.2218545 · Cited by 609
Flagged first, then by citations
2 of the 42 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 414
The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
Kim, M. Y. (2017) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2017.69.6.341 · Cited by 9
“이러한 과도한 세포자멸은 간섬유화의 주요 원인이 되는데, 세 포자멸체는 간 성상세포를 직접적으로 활성화시키고, TGFβ 와 같은 강력한 섬유화 관련 사이토카인 생산을 증가시킨다.(36)”
Husain, H., Ahmad, R., Khan, A., Inamuddin, I., & Asiri, A. M. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.168 · Cited by 10
Update on the Treatments of Non-Alcoholic Fatty Liver Disease (NAFLD)
Quercioli, A., Montecucco, F., & Mach, F. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x10909040261 · Cited by 10
“TGF- β is increased in NAFLD and might be considered as a crucial mediator in liver fibrosis [39, 40].”
BackgroundMalhi, H., & Gores, G. J. (2017) · Wiley eBooks · doi:10.1002/9781119251316.ch7 · Cited by 9
Self-citationAgalactosyl IgG induces liver fibrogenesis via Fc gamma receptor 3a on human hepatic stellate cells
Ho, C., Chang, T., Lin, H., & Wang, S. (2024) · The Journal of Pathology · doi:10.1002/path.6303 · Cited by 8
“The fi brogenic activity of HSCs is enhanced after these cells engulf apoptotic bodies [22].”
BackgroundSistema inmune y enfermedad hepática por alcohol
Laso, F. J., Pastor, I., & Órfão, A. (2005) · Medicina Clínica · doi:10.1157/13078101 · Cited by 8
Approved natural products-derived nanomedicines for disease treatment
Li, X., Yaoyao, L. A. I., Guanghan, W. A. N., Jiahui, Z. O. U., He, W., & Yang, P. (2024) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(24)60726-0 · Cited by 8
Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives
Singh, A., Akhtar, A., & Shukla, P. (2025) · ADMET & DMPK · doi:10.5599/admet.2874 · Cited by 7
“Apoptotic bodies derived from hepatocytes also play a role in stellate cell activation, without triggering an inflammatory response, and directly promote fibrogenesis [29].”
Inoue, T., Suzuki, H., & Okada, H. (2012) · Kidney International · doi:10.1038/ki.2012.243 · Cited by 7
Protective Effect of Vitamin D against Hepatic Molecular Apoptosis Caused by a High-Fat Diet in Rats
Alshaibi, H. F., Bakhashab, S., Almuhammadi, A., Althobaiti, Y. S., Baghdadi, M. A., & Alsolami, K. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45010031 · Cited by 8
“Thus, it can cause both hepatocyte apoptosis and necroptosis, which may result in chronic liver inflammation, creating a vicious cycle [19,21].”
BackgroundTsai, M.-L., Tsai, S., & Ho, C. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.07.031 · Cited by 7
Transforming Growth Factor-β Signaling in Alcohol-Associated Liver Disease
Zou, H., Wang, S., Huang, C., Dooley, S., & Meindl‐Beinker, N. M. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.09.017 · Cited by 7
Hehemann, M. C., Choe, S., Kalmanek, E., Harrington, D. A., Stupp, S. I., McVary, K. T., & Podlasek, C. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-33864-3 · Cited by 6
New Therapies in Hepatitis C Virus and Chronic Liver Disease: Antifibrotics
Rockey, D. C. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2006.08.019 · Cited by 6
Lee, Y. A., & Friedman, S. L. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch36 · Cited by 6
Self-citationMullin, S. M., Kelly, A. J., Chathail, M. B. N., Norris, S., Shannon, C. E., & Roche, H. M. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100375 · Cited by 10
“In addition to inducing the production of pro fi brogenic transforming growth factor β 1 (TGF-β 1) by macrophages, hepatocyte apoptotic bodies are also engulfed by HSCs, causing their activation [43].”
HIV-1 Tropism and Liver Fibrosis in HIV–HCV Co-Infected Patients
Abravanel, F., Raymond, S., Pambrun, É., Winnock, M., Bonnard, P., Sogni, P., Trimoulet, P., Dabis, F., Salmon, D., Izopet, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050289 · Cited by 5
“There is also evidence that the phagocytotic clearance of apoptotic debris may directly stimulate fibrogenesis [22,23,24].”
BackgroundCells in the Liver—Functions in Health and Disease
Marra, F., & Parola, M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_1 · Cited by 5
Immunopathogenesis of Autoimmune Liver Damage
Czaja, A. J. (2017) · Technical report · doi:10.1016/b978-0-444-63707-9.00002-7 · Cited by 5
Pudewell, S., Lissy, J., Nakhaeizadeh, H., Taha, M. S., Akbarzadeh, M., Adariani, S. R., Nakhaei‐Rad, S., Li, J., Kordes, C., Häussinger, D., et al. (2022) · Cells · doi:10.3390/cells11030508 · Cited by 5
“Following liver injury, quiescent HSCs (qHSCs) activate and develop into proliferative and contractile myofibroblast-like cells (aHSCs), revealing profibrogenic transcriptional properties and accounting for extracellular matrix accumulation [14,15].”
BackgroundInfluentialLi, J., Lin, L., Du, L., Xu, C., Wang, Y., Cao, J., Wang, Q., Fan, F., Wang, X., Wang, Y., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2334 · Cited by 5
“Once activated by their respective upstream signals, caspase-8 and -9 may cleave and activate downstream executioner caspases -3 and -7, which, in turn, cleave a plethora of target proteins, resulting in apoptotic death (6-8).”
FasL and Fas in Liver Homeostasis and Hepatic Injuries
Guicciardi, M. E., & Gores, G. J. (2007) · Springer eBooks · doi:10.1007/0-387-34573-6_8 · Cited by 5
Self-citationLes stéatopathies métaboliques : conséquences hépatiques du syndrome métabolique
Anty, R., Gual, P., Huet, P., MARCHAND‐BRUSTEL, Y. L., & Tran, A. (2007) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(07)78350-1 · Cited by 5
“L’hyperglycémie et l’hyperinsulinémie pourraient également stimuler la production du connective tissue growth factor (CTGF) synthétisé par les cellules stellaires.”
BackgroundInfluentialStewart, S. F., & Day, C. P. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50034-6 · Cited by 5
Gandhi, C. R. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_5 · Cited by 5
Iredale, J. P., & Guha, I. N. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch6a · Cited by 5
Species differences of fatty liver diseases: comparisons between human and feline
Ling, L., Li, R., Xu, M., Zhou, J., Hu, M., Zhang, X., & Zhang, X.-J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00014.2024 · Cited by 5
Effects of cell-type-specific expression of a pan-caspase inhibitor on renal fibrogenesis
Inoue, T., Kusano, T., Tomori, K., Nakamoto, H., Suzuki, H., & Okada, H. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1011-0 · Cited by 4
Enhanced apoptosis in post-liver transplant hepatitis C: Effects of virus and immunosuppressants
Lim, E. J. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i18.2172 · Cited by 4
Suflețel, R. T., Melincovici, C. S., Orasan, O. H., Zaharie, T., Gheban, B., Istrate, A., Constantin, A.-M., & Mihu, C. M. (2023) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-4726 · Cited by 4
“Moreover, HSCs can be indirectly activated by HCV-infected hepatocytes via TGF-β1, ubiquitin carboxyterminal hydrolase L1 (UCHL1) and various profibrogenic mediators [7, 13, 44, 74, 75].”
BackgroundResultParola, M., & Pinzani, M. (2009) · Cited by 4
Moscoso, C. G., & Steer, C. J. (2019) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s213397 · Cited by 4
“of apoptotic bodies by HSCs also promotes HSC activation.(74,75) These hepatocyte-mediated mechanisms”
BackgroundStewart, S. F., & Day, C. (2011) · Wiley eBooks · doi:10.1002/9781444341294.ch25 · Cited by 4
Malhi, H., & Gores, G. J. (2020) · doi:10.1002/9781119436812.ch17 · Cited by 4
Self-citationTao, Y., Niu, Q., Yao, Y., Wang, K., Dong, H., Zhao, X., Zeng, Z., & Li, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1528100 · Cited by 3
Malhi, H., & Gores, G. J. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_24 · Cited by 3
Self-citationCellular and Molecular Mechanism of Liver Fibrosis: A Critical Insight
Parida, G. R., Pattnaik, G., & Behera, A. (2021) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2021.01066 · Cited by 3
Structure, Function and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00001-6 · Cited by 3
Li, J., Yao, S., Zimny, S., Koob, D., Jin, H. D., Wimmer, R., Denk, G., Tuo, B., & Hohenester, S. D. (2024) · Communications Biology · doi:10.1038/s42003-024-07192-4 · Cited by 3
“4, 5 and Supplementary Fig.”
Utility of M30, an apoptotic serum marker, in liver diseases
Altınbaş, A., Çoban, Ş., Başar, Ö., & Yüksel, O. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1309-14 · Cited by 3
Hepatocyte Lethal and Nonlethal Lipotoxic Injury
Hirsova, P., Ibrahim, S. H., Malhi, H., & Gores, G. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_5 · Cited by 3
Self-citationMou, J., Wu, S., Luo, Z. Y., Guo, F., He, H., Wang, J., Lin, F., Guo, F., Sun, J., Shen, L., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.04.002 · Cited by 3
Czaja, A. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00004-7 · Cited by 3
Hepatic Fibrosis and Cirrhosis
Rockey, D. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.04206-4 · Cited by 4
Prystupa, A., Kiciński, P., Sak, J. J., Grzybowski, A. E., Boguszewska‐Czubara, A., Toruń-Jurkowska, A., & Niedziałek, J. (2017) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/75134 · Cited by 2
“Phagocytosis of apoptotic bodies by hepatic stellate cells may directly stimulate fibrogenesis, [3] which leads to the development of liver cirrhosis [4].”
BackgroundKao, C., & Ho, C. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01502-z · Cited by 2
“…they express fragment crystallizable gamma receptors (FcγRs) (Shen et al. 2005), express various clusters of differentiation markers (Vinas et al. 2003), present antigens (Vinas et al. 2003), stimulate T-lymphocyte proliferation (Vinas et al. 2003), and engulf apoptotic bodies (Canbay et al. 2003).”
Uptake Behavior of Embryonic Chick Liver Cells
Kanai, M., Murata, Y., Herbert, D. C., & Soji, T. (2007) · The Anatomical Record · doi:10.1002/ar.20557 · Cited by 2
“…of the perisinusoidal stellate cells, there have been no reports describing this phenomenon in vivo, however, these cells have recently been observed to take up apoptotic bodies (Canbay et al., 2003) or 1.01mm-diameter latex beads (Viñas et al., 2003) in vitro, when the cells are activated.”
BackgroundHepatocyte Death in Liver Inflammation, Fibrosis, and Tumorigenesis
Hsin, I., & Seki, E. (2017) · Springer eBooks · doi:10.1007/978-3-319-53774-0_10 · Cited by 2
The Promising Role of Anti-Fibrotic Agent Halofuginone in Liver Fibrosis/Cirrhosis
Karakoyun, B. (2017) · InTech eBooks · doi:10.5772/intechopen.68641 · Cited by 2
L’internista ospedaliero nella gestione del paziente diabetico complesso
Magnani, G. E. L., Beltramello, G., Brancato, D., Fontanella, A., & Nardi, R. (2018) · Italian Journal of Medicine · doi:10.4081/itjm.q.2018.2 · Cited by 2
Cellular and Molecular Pathobiology of Liver Fibrosis and its Pharmacological Intervention
Friedman, S. L. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch6b · Cited by 2
Self-citationOrphan drug uttroside B impedes MASH progression and HCC development in experimental models
Rayginia, T. P., Keerthana, C. K., Aiswarya, S. U. D., Shifana, S. C., Jannet, S., Varma, S. S., Maria Joy, P., Swetha, M., James, S., S, A. J., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101626 · Cited by 1
Hepatocyte-Derived Apoptotic Bodies as Pathological Intercellular Messengers in the Liver
New‐Aaron, M., Adepoju, L. A., Pathania, A. S., Kharbanda, K. K., & Osna, N. A. (2026) · Biomolecules · doi:10.3390/biom16020198 · Cited by 2
“While this function supports the already strained KCs during prolonged and excessive hepatocyte apoptosis, the uptake of hepatocyte ApopBDs may initiate fibrotic changes in HSCs [89].”
Label-Free Hyperspectral Raman Imaging and Analysis of a 3D Spheroid Model for Liver Fibrosis Study
Kongklad, G., Li, M., Yamashita, T., Okumura, T., Fujita, S., & Fujita, K. (2026) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.5c00243 · Cited by 1
Zheng, K., Dai, L., Wen, Y. R., Jiang, H., Gao, Y. Q., Ren, F., Tang, Y., Huang, X., 冉江华, & Chen, Y. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2690717 · Cited by 1
Obesidad y enfermedad hepática
Miquilena-Colina, M. E., & Monzón, C. G. (2010) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2009.12.009 · Cited by 1
Emerging drugs for complications of end-stage liver disease
Dowman, J. K., Holt, A. P., Newsome, P. N., & Adams, D. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.1.159 · Cited by 1
“Hepatocyte apoptosis acts as a catalyst for fibrosis by stimulating macrophage recruitment and releasing potent fibrogenic mediators into the stromal microenvironment, which promote HSC activation [122] .”
BackgroundNew Insights in the Roadmap of Liver Fibrosis Pathogenesis
El-Ahwany, E. G., & Zoheiry, M. K. (2014) · The Egyptian Journal of Hospital Medicine · doi:10.12816/0002433 · Cited by 1
“Perpetuation involves at least six distinct changes in HSC behavior, including proliferation, chemotaxis, fibrogenesis, HSCs contractility, matrix degradation and retinoid loss [17] .”
BackgroundImmunopathology of the Hepatobiliary System
Brown, D. L. (2017) · Molecular and integrative toxicology · doi:10.1007/978-3-319-47385-7_7 · Cited by 1
Chapter 7 – Replication of Hepatitis B Virus and Pathogenesis of Disease
Bartholomeusz, A., Chang, J. J., Locarnini, S., & Lewin, S. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50012-7 · Cited by 1
Stewart, S. F., & Day, C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00028-0 · Cited by 3
Fibrosis as a Major Mechanism of Chronic Liver Disease
Bechmann, L. P., & Friedman, S. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-866-9_5 · Cited by 1
Self-citationKARGARZADEH, M., Nasrabadi, M. H., Dastpak, A., & Kargarzadeh, H. (2020) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i8.38355 · Cited by 1
“Fibrogenic activity is started by engulfment of apoptotic bodies by Ito cells in these cells, and it may be how hepatocyte apoptosis promotes fibrosis [49].”
BackgroundImmunopathogenesis of Liver Cirrhosis
Guillot, A., & Gao, B. (2020) · Springer eBooks · doi:10.1007/978-3-030-51709-0_35 · Cited by 1
Szymańska, S., Markiewicz‐Kijewska, M., Pyźlak, M., Kaliciński, P., Teisseyre, J., Czubkowski, P., Karkucińska‐Więckowska, A., Kowalski, A., Stefanowicz, M., & Ismail, H. (2023) · Minerva Pediatrics · doi:10.23736/s2724-5276.23.07242-7 · Cited by 1
Stéatopathie hépatique non alcoolique
Caldéraro, J., & Zafrani, É. S. (2010) · Annales de Pathologie · doi:10.1016/j.annpat.2010.10.002 · Cited by 1
Apoptosis induced by Fas signaling does not alter hepatic hepcidin expression
Lu, S. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i3.387 · Cited by 1
Die nicht-alkoholische Fettlebererkrankung: Eine Systemerkrankung
Leven, A., Fingas, C., & Canbay, A. E. (2017) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1618950 · Cited by 1
“Die Konsequenzen einer langjährigen Leberverfettung können ähnlich sein (27, 28).”
BackgroundSelf-citationPathophysiology of Cirrhosis and Portal Hypertension
Ismail, B. S., Rivas, J. M., & Zervos, X. B. (2017) · Springer eBooks · doi:10.1007/978-3-319-52396-5_1 · Cited by 1
From fatty liver to nonalcoholic steatohepatitis with fibrosis
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00013-5 · Cited by 1
Ethanol Metabolism and Pathogenesis of Alcoholic Liver Injury
Stewart, S. F., & Day, C. (2007) · doi:10.1002/9780470691861.ch12b · Cited by 1
Duarte, C. V. G. (2009) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
NON INVASIVE EVALUATION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS B AND C
Ashraf, S. (2009) · HEC National Digital Library · Cited by 1
Chand, V. (2023) · Queensland University of Technology · doi:10.5204/thesis.eprints.249238 · Cited by 1
Serum amyloid P: A novel antifibrotic agent with therapeutic potential
Lupher, M., & Willett, W. (2010) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000320829
Silva, E. D. A. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.10.2011.tde-03042012-163500
Hepatic Stellate Cells in Hepatocellular Carcinogenesis: Possible Therapeutic Targets?
Vere, C. C. (2013) · Journal of Gastrointestinal & Digestive System · doi:10.4172/2161-069x.s12-006
“It is involved in fibrogenesis and the pro-inflammatory stimulation through apoptotic bodies phagocytized by the Kupffer cells [21].”
BackgroundKarimian, G., & Faber, K. N. (2012) · Clinical and Experimental Pharmacology · doi:10.4172/2161-1459.s3-002
“In addition, activated myofibroblast (derived from portal fibroblasts and HSCs [15,16]) are able to engulf apoptotic bodies and subsequently produce profibrogenic factors such as TGFβ and type I collagen [17,18].”
BackgroundAndrade, R. G. (2011)
Luedde, T., Kaplowitz, N., & Schwabe, R. F. (2014)
Mechanisms of Liver Cell Destruction
Malhi, H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00003-6
Nouvelles voies de mort cellulaire des hépatocytes
Filliol, A. A., Seyec, J. L., & Samson, M. (2017)
Lipotoxicity in Non-parenchymal Liver Cells
Harris, E. N., & Mott, J. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-58106-4_1
Recent research trends on the pathogenesis of nonalcoholic fatty liver disease.
Takehara, T. (2017) · PubMed · doi:10.11405/nisshoshi.114.807
Effects of LXRα phosphorylation on the regulation of lipid metabolism and hepatic fibrosis
Bécares, N. (2017) · UCL Discovery (University College London)
The Liver's Response to Injury
Cong, M., Jia, J., Kisseleva, T., & Brenner, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00005-7
Mechanisms of Fibrogenesis in NASH
Pastore, M., Gentilini, A., & Marra, F. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_6
LIVER FIBROSIS AND METHODS OF ASSESSMENT IN LIGHT OF CHRONIC HEPATITIS DELTA
WANI, S. T., & Turcanu, A. I. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4744451
Apoptosis and oncotic necrosis: profibrotic signalling mechanisms of cell death
Jaeschke, H., & Hong, J. Y. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8656-4_1
Special Lecture: Anti-apoptotic intervention as a novel treatment option in liver diseases
Canbay, A. E., & Gores, G. J. (2007) · Springer eBooks · doi:10.1007/1-4020-5224-3_13
Self-citationPostgraduate Course: Integrating Basic Science into Clinical Practice
Jo, J., & Thimme, R. (2010) · Hepatology International · doi:10.1007/s12072-010-9173-7
Stewart, S. F., & Forrest, E. H. (2018) · Wiley eBooks · doi:10.1002/9781119237662.ch25
Cells, cytokines, and factors involved in profibrogenic pathways
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00014-7
Calvert, B. A., & Ryan, A. L. (2023) · Physiology · doi:10.5772/intechopen.110583
The liver sinusoid in acute-on-chronic liver failure
Schierwagen, R., Brol, M. J., Klein, S., Uschner, F. E., & Trebicka, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95262-0.00016-4
Rayginia, T. P., Keerthana, C. K., Aiswarya, S. U. D., Shifana, S. C., Jannet, S., Varma, S. S., Maria, J. P., Swetha, M., Retnakumari, A. P., Nath, L. R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.06.622394
Schwabl, P., Papatheodoridi, Μ., & Pinzani, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-823524-9.00005-8
Metadata
- Authors
- Canbay, A., Taimr, P., Torok, N., Higuchi, H., Friedman, S., & Gores, G. J.
- Affiliations
- Mayo Clinic (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Gores, Gregory J
- Venue
- Laboratory Investigation
- Publisher
- Elsevier BV
- Published
- 2003-05
- Volume
- 83
- Issue
- 5
- Pages
- 655-663
- ISSN
- 0023-6837 (ISSN-L)
- OpenAlex
- W2089907961
- Cited by
- 417
- References
- 42
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 13 · 2023: 23 · 2022: 15 · 2021: 19 · 2020: 29 · 2019: 10 · 2018: 20 · 2017: 31 · 2016: 13 · 2015: 11 · 2014: 33 · 2013: 13 · 2012: 18
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Laboratory Investigation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Mayo Foundation for Medical Education and Research
- US-UK Fulbright Commission
- Deutscher Akademischer Austauschdienst
- National Institutes of Health (DK 41876, DK56621)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK37430, DK 56621, DK-41876)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- hepatic stellate cells, hepatocyte apoptosis, liver fibrosis, TGF-β1, stellate cell activation, PI3K signaling, p38 MAPK signaling, chronic liver disease
- MeSH terms
- Cell Line, Humans, Liver Cirrhosis, Microtubules, RNA, Messenger, Nocodazole, Transforming Growth Factor beta, Apoptosis, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Hepatocytes, Collagen Type I, p38 Mitogen-Activated Protein Kinases, Transforming Growth Factor beta1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
